2017Traditional Chinese MedicineRequires access

A clinical research of Lingshao-Zaoren granule for the female with overactive bladder symptom: a randomized, double-blind, placebo-controlled trial

Jianwu Shen, Zhan Gao, Lin Zhang, Kuiqing Shao, Ran Luo, Qi Li, Pengxu Qin, Yujin Li, Yi Zhao

Open publisher page 0 citations

Abstract

Objective To evaluate the effectiveness of Lingshao-Zaoren granule in the treatment of female overactive bladder. Methods A total of 60 female OAB patients who met the inclusion criteria were randomly divided into 2 groups, 30 cases in each group. The control group recieved the Tolterodine Tartrate Sustained Release Tablets and the Lingshao-Zaoren granule placebo, and the treatment group used the Tolterodine Tartrate Sustained Release Tablets and the true Lingshao-Zaoren granule treatment. Both groups were treated for 4 weeks. Overactive bladder symptom scale (OABSS) was used to determine the severity of OAB. Results After treatment 14, 28 d, OABSS scores of the treatment group (5.3 ± 2.3, 1.4 ± 1.2 vs. 8.4 ± 2.4, F=137.209), and control group (7.8 ± 1.9, 6.8 ± 1.4 vs. 8.6 ± 2.6, F=8.927), were significantly lower than the baseline of each group respectively (P<0.01). Besides, OABSS scores of the treatment group after 14 and 28 d were significantly lower than the control group (t=4.668, 15.678, P<0.01). The pain scores (5.9 ± 1.9, 2.7 ± 1.1 vs. 9.5 ± 2.3, F=108.819) of treatment group at 14 and 28 d were significantly lower than the baseline (P<0.01); and the pain scores of treatment group at 14 and 28 d were significantly lower than the control group (t=6.342, 14.812, P<0.01). The lower abdomen discomfort scores at 14, 28 d in treatment group (1.9 ± 1.4, 1.1 ± 1.0 vs. 3.3 ± 1.1, F=28.762), and control group (2.7 ± 1.0, 2.4 ± 0.8 vs. 3.4 ± 1.2, F=12.103) were significantly lower than the baseline of each group (P<0.01); and the abdominal discomfort scores of treatment group at 14, 28 d were significantly lower than the control group (t=2.521, 5.041, P<0.05 or P<0.01). Conclusions The Lingshao-Zaoren granule could decrease OABSS score, pain score, abdominal discomfort symptoms, improve clinical symptoms of the female patients with OAB. Key words: Urinary bladder, overactive; Female; Lingshao-Zaoren granule; Integrated Chinese traditional and western medicine therapy; Overactive bladder symptom scale

About this research paper

What this paper is about

Objective To evaluate the effectiveness of Lingshao-Zaoren granule in the treatment of female overactive bladder. Methods A total of 60 female OAB patients who met the inclusion criteria were randomly divided into 2 groups, 30 cases in each group. The control group recieved the Tolterodine Tartrate Sustained Release Tablets and the Lingshao-Zaoren granule placebo, and the treatment group used the Tolterodine Tartrate Sustained Release Tablets and the true Lingshao-Zaoren granule treatment. Both groups were treated for 4 weeks. Overactive bladder symptom scale (OABSS) was used to determine the severity of OAB. Results After treatment 14, 28 d, OABSS scores of the treatment group (5.3 ± 2.3, 1.4 ± 1.2 vs. 8.4 ± 2.4, F=137.209), and control group (7.8 ± 1.9, 6.8 ± 1.4 vs. 8.6 ± 2.6, F=8.927), were significantly lower than the baseline of each group respectively (P<0.01). Besides, OABSS scores of the treatment group after 14 and 28 d were significantly lower than the control group (t=4.668, 15.678, P<0.01). The pain scores (5.9 ± 1.9, 2.7 ± 1.1 vs. 9.5 ± 2.3, F=108.819) of treatment group at 14 and 28 d were significantly lower than the baseline (P<0.01); and the pain scores of treatment group at 14 and 28 d were significantly lower than the control group (t=6.342, 14.812, P<0.01). The lower abdomen discomfort scores at 14, 28 d in treatment group (1.9 ± 1.4, 1.1 ± 1.0 vs. 3.3 ± 1.1, F=28.762), and control group (2.7 ± 1.0, 2.4 ± 0.8 vs. 3.4 ± 1.2, F=12.103) were significantly lower than the baseline of each group (P<0.01); and the abdominal discomfort scores of treatment group at 14, 28 d were significantly lower than the control group (t=2.521, 5.041, P<0.05 or P<0.01). Conclusions The Lingshao-Zaoren granule could decrease OABSS score, pain score, abdominal discomfort symptoms, improve clinical symptoms of the female patients with OAB. Key words: Urinary bladder, overactive; Female; Lingshao-Zaoren granule; Integrated Chinese traditional and western medicine therapy; Overactive bladder symptom scale

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effectiveness of Lingshao-Zaoren granule in the treatment of female overactive bladder. Methods A total of 60 female OAB patients who met the inclusion criteria were randomly divided into 2 groups, 30 cases in each group. The control group recieved the Tolterodine Tartrate Sustained Release Tablets and the Lingshao-Zaoren granule placebo, and the treatment group used the Tolterodine Tartrate Sustained Release Tablets and the true Lingshao-Zaoren granule treatment. Both groups were treated for 4 weeks. Overactive bladder symptom scale (OABSS) was used to determine the severity of OAB. Results After treatment 14, 28 d, OABSS scores of the treatment group (5.3 ± 2.3, 1.4 ± 1.2 vs. 8.4 ± 2.4, F=137.209), and control group (7.8 ± 1.9, 6.8 ± 1.4 vs. 8.6 ± 2.6, F=8.927), were significantly lower than the baseline of each group respectively (P<0.01). Besides, OABSS scores of the treatment group after 14 and 28 d were significantly lower than the control group (t=4.668, 15.678, P<0.01). The pain scores (5.9 ± 1.9, 2.7 ± 1.1 vs. 9.5 ± 2.3, F=108.819) of treatment group at 14 and 28 d were significantly lower than the baseline (P<0.01); and the pain scores of treatment group at 14 and 28 d were significantly lower than the control group (t=6.342, 14.812, P<0.01). The lower abdomen discomfort scores at 14, 28 d in treatment group (1.9 ± 1.4, 1.1 ± 1.0 vs. 3.3 ± 1.1, F=28.762), and control group (2.7 ± 1.0, 2.4 ± 0.8 vs. 3.4 ± 1.2, F=12.103) were significantly lower than the baseline of each group (P<0.01); and the abdominal discomfort scores of treatment group at 14, 28 d were significantly lower than the control group (t=2.521, 5.041, P<0.05 or P<0.01). Conclusions The Lingshao-Zaoren granule could decrease OABSS score, pain score, abdominal discomfort symptoms, improve clinical symptoms of the female patients with OAB. Key words: Urinary bladder, overactive; Female; Lingshao-Zaoren granule; Integrated Chinese traditional and western medicine therapy; Overactive bladder symptom scale

Key concepts: Overactive bladder, Tolterodine, Medicine, Placebo, Randomized controlled trial, Placebo-controlled study, Granule (geology), Urology

Related papers

Back to paper searchBrowse research topicsOriginal source
A clinical research of Lingshao-Zaoren granule for the female with overactive bladder symptom: a randomized, double-blind, placebo-controlled trial — Research Paper | ScholarLens